Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Epidemiology, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.
J Alzheimers Dis. 2024;100(1):163-174. doi: 10.3233/JAD-240247.
The Adult Changes in Thought (ACT) study is a cohort of Kaiser Permanente Washington members ages 65+ that began in 1994.
We wanted to know how well ACT participants represented all older adults in the region, and how well ACT findings on eye disease and its relationship with Alzheimer's disease generalized to all older adults in the Seattle Metropolitan Region.
We used participation weights derived from pooling ACT and Behavioral Risk Factor Surveillance System (BRFSS) data to estimate prevalences of common eye diseases and their associations with Alzheimer's disease incidence. Cox proportional hazards models accounted for age, education, smoking, sex, and APOE genotype. Confidence intervals for weighted analyses were bootstrapped to account for error in estimating the weights.
ACT participants were fairly similar to older adults in the region. The largest differences were more self-reported current cholesterol medication use in BRFSS and higher proportions with low education in ACT. Incorporating the weights had little impact on prevalence estimates for age-related macular degeneration or glaucoma. Weighted estimates were slightly higher for diabetic retinopathy (weighted 5.7% (95% Confidence Interval 4.3, 7.1); unweighted 4.1% (3.6, 4.6)) and cataract history (weighted 51.8% (49.6, 54.3); unweighted 48.6% (47.3, 49.9)). The weighted hazard ratio for recent diabetic retinopathy diagnosis and Alzheimer's disease was 1.84 (0.34, 4.29), versus 1.32 (0.87, 2.00) in unweighted ACT.
Most, but not all, associations were similar after participation weighting. Even in community-based cohorts, extending inferences to broader populations may benefit from evaluation with participation weights.
成人思维变化(ACT)研究是一个由 Kaiser Permanente Washington 的 65 岁以上成员组成的队列,始于 1994 年。
我们想知道 ACT 参与者在该地区的所有老年人中代表性如何,以及 ACT 关于眼病及其与阿尔茨海默病关系的研究结果在多大程度上推广到西雅图大都市区的所有老年人。
我们使用从 ACT 和行为风险因素监测系统(BRFSS)数据中提取的参与权重来估计常见眼病的患病率及其与阿尔茨海默病发病的关联。Cox 比例风险模型考虑了年龄、教育程度、吸烟、性别和 APOE 基因型。加权分析的置信区间通过对权重进行 bootstrap 来估计误差。
ACT 参与者与该地区的老年人相当相似。最大的差异是 BRFSS 中报告的当前胆固醇药物使用更多,而 ACT 中受教育程度较低的比例更高。纳入权重对年龄相关性黄斑变性或青光眼的患病率估计影响不大。加权估计值略高一些,糖尿病视网膜病变(加权 5.7%(95%置信区间 4.3,7.1);未加权 4.1%(3.6,4.6))和白内障病史(加权 51.8%(49.6,54.3);未加权 48.6%(47.3,49.9))。最近糖尿病视网膜病变诊断与阿尔茨海默病的加权风险比为 1.84(0.34,4.29),而未加权 ACT 为 1.32(0.87,2.00)。
大多数(但不是全部)关联在参与加权后相似。即使在社区为基础的队列中,通过参与权重评估也可能有助于将结论推广到更广泛的人群。